World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02354352
Date of registration: 27/01/2015
Prospective Registration: Yes
Primary sponsor: Ohio State University
Public title: Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Scientific title: Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Date of first enrolment: March 20, 2015
Target sample size: 52
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02354352
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 3
Countries of recruitment
United States
Contacts
Name:     Subha V Raman, MD
Address: 
Telephone:
Email:
Affiliation:  Ohio State University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Boys age =7 years with DMD confirmed clinically and by mutation analysis able to
undergo cardiac magnetic resonance (CMR) without sedation

- LV EF =45% (+/-5%) by clinically-acquired echocardiography, nuclear scan or cardiac
MRI done within 2 weeks of enrollment

Exclusion Criteria:

- Non-MR compatible implants

- Severe claustrophobia

- Gadolinium contrast allergy

- Kidney disease

- Prior use of or allergy to aldosterone antagonist

- Use of other investigational therapy.



Age minimum: 7 Years
Age maximum: N/A
Gender: Male
Health Condition(s) or Problem(s) studied
Duchenne Muscular Dystrophy
Intervention(s)
Drug: Eplerenone
Drug: Spironolactone
Primary Outcome(s)
Left Ventricular Strain [Time Frame: 12 months]
Secondary Outcome(s)
Secondary ID(s)
2014H0387
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Utah
University of Kansas Medical Center
University of California, Los Angeles
University of Colorado, Denver
Vanderbilt University Medical Center
Ethics review
Results
Results available: Yes
Date Posted: 24/09/2019
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT02354352
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history